ZA934036B - Novel steroids with pregnane skeleton, pharmaceutical compositions containing them and process for preparing same. - Google Patents

Novel steroids with pregnane skeleton, pharmaceutical compositions containing them and process for preparing same.

Info

Publication number: ZA934036B
Authority: ZA; South Africa
Prior art keywords: pharmaceutical compositions; compositions containing; preparing same; novel steroids; pregnane skeleton
Prior art date: 1992-06-09

Application number

ZA934036A

Other languages

English (en)

Inventor

Sandor Maho

Zoltan Tuba

Aniko Gere

Pal Vittay

Bela Kiss

Eva Palosi

Laszlo Szporny

Czinege Erzsebet Francsicsne

Lajosne Dr Boor

Gabor Balogh

Sandor Goeroeg

Original Assignee

Richter Gedeon Vegyeszet

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-06-09

Filing date

1993-06-08

Publication date

1994-01-06

1993-06-08 Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet

1994-01-06 Publication of ZA934036B publication Critical patent/ZA934036B/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/50—Three nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Obesity (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Hematology (AREA)
Diabetes (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)

ZA934036A 1992-06-09 1993-06-08 Novel steroids with pregnane skeleton, pharmaceutical compositions containing them and process for preparing same. ZA934036B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
HU9201910A HU212308B (en)	1992-06-09	1992-06-09	Process for producing novel pregnane steroids and pharmaceutical compositions containing the same

Publications (1)

Publication Number	Publication Date
ZA934036B true ZA934036B (en)	1994-01-06

Family

ID=10982020

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA934036A ZA934036B (en)	1992-06-09	1993-06-08	Novel steroids with pregnane skeleton, pharmaceutical compositions containing them and process for preparing same.

Country Status (17)

Country	Link
US (1)	US5547949A (fi)
EP (1)	EP0646126A1 (fi)
JP (1)	JPH07507792A (fi)
KR (1)	KR950701933A (fi)
AU (1)	AU4352393A (fi)
CA (1)	CA2136546A1 (fi)
CZ (1)	CZ308094A3 (fi)
EE (1)	EE9400071A (fi)
FI (1)	FI945781A (fi)
HR (1)	HRP930956A2 (fi)
HU (1)	HU212308B (fi)
IL (1)	IL105943A0 (fi)
NO (1)	NO944749L (fi)
RU (1)	RU94046369A (fi)
SI (1)	SI9300311A (fi)
WO (1)	WO1993025570A1 (fi)
ZA (1)	ZA934036B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69942578D1 (de)	1998-05-22	2010-08-26	Univ R	Bifunktionelle moleküle sowie darauf basierende therapien.
US20040127502A1 (en) *	2001-01-31	2004-07-01	Synaptic Pharmaceutical Corporation	Use of GAL3 antagonist for treatment of depression
US7081470B2 (en) *	2001-01-31	2006-07-25	H. Lundbeck A/S	Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
MY141867A (en) *	2002-06-20	2010-07-16	Vertex Pharma	Substituted pyrimidines useful as protein kinase inhibitors
DK1889198T3 (da)	2005-04-28	2015-02-09	Proteus Digital Health Inc	Farma-informatiksystem
US9062126B2 (en)	2005-09-16	2015-06-23	Raptor Pharmaceuticals Inc.	Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
NL2000323C2 (nl) *	2005-12-20	2007-11-20	Pfizer Ltd	Pyrimidine-derivaten.
EP2805720B1 (en)	2008-05-28	2019-08-07	ReveraGen BioPharma, Inc.	Non-hormonal steroid modulators of NF-KB for treatment of disease
AU2010216512B2 (en)	2009-02-20	2016-06-30	2-Bbb Medicines B.V.	Glutathione-based drug delivery system
MY163048A (en)	2009-05-06	2017-08-15	Laboratory Skin Care Inc	Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
EP2556083A4 (en)	2010-04-05	2013-12-04	Validus Biopharma Inc	NONHORMONAL STEROID MODULATORS OF NF-KAPPA-B FOR DISEASE TREATMENT
WO2017004205A1 (en)	2015-06-29	2017-01-05	Reveragen Biopharma, Inc.	NON-HORMONAL STEROID MODULATORS OF NF-κB FOR TREATMENT OF DISEASE
US11382922B2 (en)	2019-03-07	2022-07-12	Reveragen Biopharma, Inc.	Aqueous oral pharmaceutical suspension compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5099019A (en) *	1985-09-12	1992-03-24	Upjohn Company	Amines useful in producing pharmaceutically active CNS compounds
ES2078890T3 (es) *	1986-10-09	1996-01-01	Upjohn Co	Amino esteroides en c20 a c26.
FR2644789B1 (fr) *	1989-03-22	1995-02-03	Roussel Uclaf	Nouveaux steroides 19-nor, 3-ceto comportant une chaine en 17 aminosubstituee, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant
FR2644787B1 (fr) *	1989-03-22	1995-02-03	Roussel Uclaf	Nouveaux steroides 21 aminosubstitues, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant
CA2071000A1 (en) *	1990-01-26	1991-07-27	John M. Mccall	5-oxygenated-2,4,6-triaminopyrimidines

1992
- 1992-06-09 HU HU9201910A patent/HU212308B/hu not_active IP Right Cessation
1993
- 1993-06-08 EP EP93913455A patent/EP0646126A1/en not_active Withdrawn
- 1993-06-08 WO PCT/HU1993/000035 patent/WO1993025570A1/en not_active Application Discontinuation
- 1993-06-08 KR KR1019940704496A patent/KR950701933A/ko not_active Application Discontinuation
- 1993-06-08 IL IL105943A patent/IL105943A0/xx unknown
- 1993-06-08 HR HRP930956AA patent/HRP930956A2/hr not_active Application Discontinuation
- 1993-06-08 JP JP6501316A patent/JPH07507792A/ja active Pending
- 1993-06-08 CA CA002136546A patent/CA2136546A1/en not_active Abandoned
- 1993-06-08 ZA ZA934036A patent/ZA934036B/xx unknown
- 1993-06-08 US US08/351,448 patent/US5547949A/en not_active Expired - Fee Related
- 1993-06-08 AU AU43523/93A patent/AU4352393A/en not_active Abandoned
- 1993-06-08 CZ CZ943080A patent/CZ308094A3/cs unknown
- 1993-06-09 SI SI9300311A patent/SI9300311A/sl unknown
1994
- 1994-06-29 EE EE9400071A patent/EE9400071A/xx unknown
- 1994-12-06 RU RU94046369/04A patent/RU94046369A/ru unknown
- 1994-12-08 FI FI945781A patent/FI945781A/fi not_active Application Discontinuation
- 1994-12-08 NO NO944749A patent/NO944749L/no unknown

Also Published As

Publication number	Publication date
KR950701933A (ko)	1995-05-17
SI9300311A (sl)	1993-12-31
HUT64562A (en)	1994-01-28
EE9400071A (et)	1995-12-15
HU9201910D0 (en)	1992-09-28
FI945781A0 (fi)	1994-12-08
IL105943A0 (en)	1993-10-20
AU4352393A (en)	1994-01-04
JPH07507792A (ja)	1995-08-31
HU212308B (en)	1996-05-28
EP0646126A1 (en)	1995-04-05
WO1993025570A1 (en)	1993-12-23
HRP930956A2 (hr)	1995-02-28
FI945781A (fi)	1994-12-08
RU94046369A (ru)	1996-09-27
NO944749D0 (no)	1994-12-08
CZ308094A3 (en)	1995-11-15
US5547949A (en)	1996-08-20
CA2136546A1 (en)	1993-12-23
NO944749L (no)	1995-02-08

Similar Documents

Publication	Publication Date	Title
IL128601A (en)	2003-07-31	7alpha-(epsilon-AMINOALKYL) ESTRATRIENES, PROCESS FOR PREPARING THE SAME, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 7alpha-(epsilon-AMINOALKYL) ESTRATRIENES AND THEIR USE FOR PREPARING MEDICAMENTS
HUT64734A (en)	1994-02-28	Anthraquinone-derivativdes, process for preparing them and pharmaceutical compositions containing them
GR3032732T3 (en)	2000-06-30	Amido-3-pyrazole derivatives, process for their preparation and pharmaceutical compositions containing them.
HUP9603495A3 (en)	1998-04-28	1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, pharmaceutical compositions containing the same and process for their preparation
HUT65903A (en)	1994-07-28	Oxamides, process for preparing them and pharmaceutical compositions containing them
ZA859756B (en)	1986-09-24	Peptide-aldehydes,process for the preparation thereof and pharmaceutical compositions containing the same
HUT73772A (en)	1996-09-30	Novel erythromycin derivatives, method for preparing same and pharmaceutical compositions containing the same
EP0263569A3 (en)	1988-07-20	9-alpha-hydroxysteroids,process for their preparation,process for the preparation of the corresponding 9(11)-dehydro-derivatives and pharmaceutical preparations containing said steroids
AU646112B2 (en)	1994-02-10	N,O-sulphated heparosans, process for preparing them and pharmaceutical compositions containing them
HU9402078D0 (en)	1994-09-28	Phthalazin-1-ones and phtalazin-1-thiones, composhions containing them and process for thei preparation
ZA916291B (en)	1992-04-29	Corticoid-17-alkylcarbonates substituted in the 17-position,process for their preparation and pharmaceuticals containing them
ZA934036B (en)	1994-01-06	Novel steroids with pregnane skeleton, pharmaceutical compositions containing them and process for preparing same.
IL105348A0 (en)	1993-08-18	Azabicyclo derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
HU9400934D0 (en)	1994-06-28	Thiadiazinone derivatives, pharmaceutical compositions containing them and process for producing them
IL96366A0 (en)	1991-08-16	Steroids,their manufacture and pharmaceutical compositions containing them
ZA901752B (en)	1991-05-29	Steroid diols,pharmaceutical compositions containing them and process for preparing same
ZA901753B (en)	1990-12-28	Steroid derivatives,pharmaceutical compositions containing them and process for preparing same
ZA9810358B (en)	1999-11-12	19-Nor steroids substituted in position 11beta, preparation process and intermediates, their use as medicaments and pharmaceutical compositions containing them.
AU4756693A (en)	1994-03-31	1-heteroarylazetidines and -pyrrolidines, process for their preparation and pharmaceutical compositions containing them
HU210798A9 (en)	1995-07-28	Novel steroids with pregnane skeleton, pharmaceutical compositions containing them and process for preparing same
LV10282B (en)	1995-04-20	Novel steroids with pregnane skeleton, pharmaceutical compositions containing them and process for preparing same
IL59934A (en)	1983-06-15	4-diazo steroids,process for their preparation and pharmaceutical compositions containing them
DE2960090D1 (en)	1981-03-19	Testosterone esters, process for their preparation and pharmaceutical compositions containing them
HU9402919D0 (en)	1995-01-30	Heteroaryl-piperidine derivatives, process for producing them and pharmaceutical compositions containing them
PL345073A1 (en)	2001-12-03	Novel 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same